Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Vimentin phosphorylation by Cdc2 in Schwann cell controls axon growth via β1-integrin activation.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20120601
Title: Role of cell cycle-associated proteins in microglial proliferation in the axotomized rat facial nucleus.
Journal: Glia 20120401
Title: Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in Caco-2 colon cancer cells.
Journal: Molecular medicine reports 20120401
Title: Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone.
Journal: Pharmacological research 20120301
Title: Regulation of a Myb transcription factor by cyclin-dependent kinase 2 in Giardia lamblia.
Journal: The Journal of biological chemistry 20120203
Title: Computational design of targeted inhibitors of polo-like kinase 1 (plk1).
Journal: Bioinformatics and biology insights 20120101
Title: The biocompatibility of nanodiamonds and their application in drug delivery systems.
Journal: Theranostics 20120101
Title: An anillin-Ect2 complex stabilizes central spindle microtubules at the cortex during cytokinesis.
Journal: PloS one 20120101
Title: IspE inhibitors identified by a combination of in silico and in vitro high-throughput screening.
Journal: PloS one 20120101
Title: Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells.
Journal: PloS one 20120101
Title: Cyclin B1 interacts with the BH3-only protein Bim and mediates its phosphorylation by Cdk1 during mitosis.
Journal: Cell cycle (Georgetown, Tex.) 20111115
Title: VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells.
Journal: Cancer biology & therapy 20111101
Title: Cell cycle regulators are critical for maintaining the differentiation potential and immaturity in adipogenesis of adipose-derived stem cells.
Journal: Differentiation; research in biological diversity 20111001
Title: A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor.
Journal: Oncogene 20110728
Title: Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
Journal: Bioorganic & medicinal chemistry 20110415
Title: LiCl induces TNF-α and FasL production, thereby stimulating apoptosis in cancer cells.
Journal: Cell communication and signaling : CCS 20110101
Title: Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection.
Journal: PloS one 20110101
Title: Acute toxicity of the antifouling compound butenolide in non-target organisms.
Journal: PloS one 20110101
Title: The Cryptosporidium parvum kinome.
Journal: BMC genomics 20110101
Title: Phosphorylation of AIB1 at mitosis is regulated by CDK1/CYCLIN B.
Journal: PloS one 20110101
Title: The yeast three-hybrid system as an experimental platform to identify proteins interacting with small signaling molecules in plant cells: potential and limitations.
Journal: Frontiers in plant science 20110101
Title: Noise cancellation: viral fine tuning of the cellular environment for its own genome replication.
Journal: PLoS pathogens 20101201
Title: Cell cycle-dependent regulation of the forkhead transcription factor FOXK2 by CDK·cyclin complexes.
Journal: The Journal of biological chemistry 20101112
Title: Purvalanol A, a CDK inhibitor, effectively suppresses Src-mediated transformation by inhibiting both CDKs and c-Src.
Journal: Genes to cells : devoted to molecular & cellular mechanisms 20101001
Title: VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.
Journal: Cancer biology & therapy 20100815
Title: Mitotane sensitizes adrenocortical cancer cells to ionizing radiations by involvement of the cyclin B1/CDK complex in G2 arrest and mismatch repair enzymes modulation.
Journal: International journal of oncology 20100801
Title: Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.
Journal: Antiviral research 20100601
Title: Simultaneous detection of intracellular target and off-target binding of small molecule cancer drugs at nanomolar concentrations.
Journal: British journal of pharmacology 20100601
Title: Comprehensive screening of human genes with inhibitory effects on yeast growth and validation of a yeast cell-based system for screening chemicals.
Journal: Journal of biomolecular screening 20100401
Title: Inhibition of human immunodeficiency virus type-1 by cdk inhibitors.
Journal: AIDS research and therapy 20100101
Title: Natural product Celastrol destabilizes tubulin heterodimer and facilitates mitotic cell death triggered by microtubule-targeting anti-cancer drugs.
Journal: PloS one 20100101
Title: Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells.
Journal: PloS one 20100101
Title: Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis.
Journal: Advances in pharmacological sciences 20100101
Title: Nanodiamond-mediated delivery of water-insoluble therapeutics.
Journal: ACS nano 20090728
Title: Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation.
Journal: PLoS biology 20090501
Title: Cellular phototoxicity evoked through the inhibition of human ABC transporter ABCG2 by cyclin-dependent kinase inhibitors in vitro.
Journal: Pharmaceutical research 20090201
Title: Structural insights into the inhibited states of the Mer receptor tyrosine kinase.
Journal: Journal of structural biology 20090201
Title: Establishment of human papillomavirus infection requires cell cycle progression.
Journal: PLoS pathogens 20090201
Title: The utilization of humanized mouse models for the study of human retroviral infections.
Journal: Retrovirology 20090101
Title: Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.
Journal: PloS one 20090101
Title: Purvalanol A induces apoptosis and downregulation of antiapoptotic proteins through abrogation of phosphorylation of JAK2/STAT3 and RNA polymerase II.
Journal: Anti-cancer drugs 20080701
Title: Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation.
Journal: The Journal of biological chemistry 20080627
Title: Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility.
Journal: Nature chemical biology 20080601
Title: Oxidative amination of cuprated pyrimidine and purine derivatives.
Journal: Organic letters 20080501
Title: Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways.
Journal: AIDS research and therapy 20080101
Title: Standardized high-throughput evaluation of cell-based compound screens.
Journal: BMC bioinformatics 20080101
Title: [Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors].
Journal: Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme 20071001
Title: Cyclin-dependent kinase inhibitors block erythrocyte invasion and intraerythrocytic development of Babesia bovis in vitro.
Journal: Parasitology 20070901
Title: The molecular genetics of breast cancer and targeted therapy.
Journal: Biologics : targets & therapy 20070901
Title: Purvalanol A enhances cell killing by inhibiting up-regulation of CDC2 kinase activity in tumor cells irradiated with high doses of X rays.
Journal: Radiation research 20070501
Title: The mitotic manipulation of cytotrophoblast differentiation in vitro.
Journal: Placenta 20070101
Title: Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells.
Journal: International journal of radiation oncology, biology, physics 20061101
Title: p27 small interfering RNA induces cell death through elevating cell cycle activity in cultured cortical neurons: a proof-of-concept study.
Journal: Cellular and molecular life sciences : CMLS 20061001
Title: Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2.
Journal: Journal of the American Society of Nephrology : JASN 20060901
Title: Cellular stress increases RGS2 mRNA and decreases RGS4 mRNA levels in SH-SY5Y cells.
Journal: Neuroscience letters 20060724
Title: Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo.
Journal: The Journal of biological chemistry 20060616
Title: p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells.
Journal: PLoS biology 20060301
Title: Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Journal: Chemical biology & drug design 20060101
Title: Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner.
Journal: The Journal of biological chemistry 20051028
Title: Crystal structures of active SRC kinase domain complexes.
Journal: Journal of molecular biology 20051021
Title: Ligand binding affinity determined by temperature-dependent circular dichroism: cyclin-dependent kinase 2 inhibitors.
Journal: Analytical biochemistry 20051015
Title: Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.
Journal: Molecular cancer therapeutics 20050901
Title: Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism.
Journal: Oncogene 20050714
Title: Characterization of two T. gondii CK1 isoforms.
Journal: Molecular and biochemical parasitology 20050501
Title: Purvalanol A, inhibitor of cyclin-dependent kinases attenuates proliferation of cells in the dentate gyrus of the adult rat hippocampus.
Journal: Pharmacological reports : PR 20050101
Title: The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death.
Journal: The American journal of pathology 20041001
Title: Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons.
Journal: Biochemical pharmacology 20040515
Title: Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
Journal: The Journal of biological chemistry 20040507
Title: Protein kinases as targets for anti-parasitic chemotherapy.
Journal: Biochimica et biophysica acta 20040311
Title: Viral and cellular kinases are potential antiviral targets and have a central role in varicella zoster virus pathogenesis.
Journal: Biochimica et biophysica acta 20040311
Title: Cassette dosing pharmacokinetics of a library of 2,6,9-trisubstituted purine cyclin-dependent kinase 2 inhibitors prepared by parallel synthesis.
Journal: Molecular cancer therapeutics 20040301
Title: A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors.
Journal: Chemistry & biology 20040201
Title: c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells.
Journal: British journal of cancer 20031020
Title: The specificities of protein kinase inhibitors: an update.
Journal: The Biochemical journal 20030401
Title: Synthesis and biological activity of olomoucine II.
Journal: Bioorganic & medicinal chemistry letters 20021118
Title: p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.
Journal: Oncogene 20020919
Title: Progress toward virtual screening for drug side effects.
Journal: Proteins 20020901
Title: Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.
Journal: Journal of virology 20020801
Title: Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors.
Journal: Molecular and cellular biochemistry 20020801
Title: Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes.
Journal: Journal of medicinal chemistry 20020606
Title: Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities.
Journal: International journal of cancer 20020220
Title: Characterization of a human colorectal carcinoma cell line with acquired resistance to flavopiridol.
Journal: Molecular pharmacology 20011101
Title: Cell cycle-dependent control of polarised development by a cyclin-dependent kinase-like protein in the Fucus zygote.
Journal: Development (Cambridge, England) 20011101
Title: Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum.
Journal: Biochemical pharmacology 20010801
Title: Applications of microarray technology in breast cancer research.
Journal: Breast cancer research : BCR 20010101
Title: Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.
Journal: Science (New York, N.Y.) 19980724
Title: Gray NS, et, al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 1998 Jul 24;281(5376):533-8.
Title: Bullard KM, et, al. Effects of cyclin-dependent kinase inhibitor Purvalanol B application on protein expression and developmental progression in intra-erythrocytic Plasmodium falciparum parasites. Malar J. 2015 Apr 8;14:147.
